Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN Печать: 0893-9675
ISSN Онлайн: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2020032954
pages 339-347

Epstein-Barr Virus and Astrocytoma

Cristiana Freixo
Pediatric Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal
Sylvie Hermouet
CRCINA, Inserm, Université de Nantes, Université d'Angers, Nantes, France
Ana Margarida Neves
Pediatric Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal

Краткое описание

Epstein-Barr virus (EBV) is an established pathogen linked to a wide range of lymphoproliferative disorders and solid tumors. Astrocytoma is one of the most frequent brain tumors in children, adolescents, and young adults. Astrocyte proliferation usually occurs after brain tissue aggression, which may be of different types, including viral infection. In particular, it has been suggested that EBV may play a role in astrocytoma pathogenesis. This article presents the summarized results of a systematic review of the literature on the relationship between EBV infection and astrocytoma pathophysiology. Although most studies detect the presence of EBV DNA in subsets of astrocytoma tumors, our conclusion is that currently, except for rare cases, there is no clear evidence that EBV plays a role in the development of astrocytoma.


  1. Rovnak J, Quackenbush SL, Reyes RA, Baines JD, Parrish CR, Casey JW. Detection of a novel bovine lymphotropic herpesvirus. J Virol. 1998;72(5):4237-42.

  2. Jenson HB. Epstein-Barr virus. Pediatr Rev. 2011;32(9): 375-83.

  3. Akhtar S, Vranic S, Cyprian FS, Al Moustafa A-E. Epstein-Barr virus in gliomas: cause, association, or artifact? Front Oncol. 2018;8(April):1-10.

  4. Thorley-Lawson DA. EBV persistence-introducing the virus. In: Epstein Barr virus. Springer International Publishing; 2015. p. 151-209.

  5. Elgui de Oliveira D, Muller-Coan BG, Pagano JS. Viral carcinogenesis beyond malignant transformation: EBV in the progression of human cancers. Trends Microbiol. 2016;24(8):649-664.

  6. Morales-Sanchez A, Fuentes-Panana EM. Epstein-Barr virus-associated gastric cancer and potential mechanisms of oncogenesis. Curr Cancer Drug Targets. 2017;17(6): 534-54.

  7. Kenney SC. Reactivation and lytic replication of EBV. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 25.

  8. Odumade OA, Hogquist KA, Balfour Jr HH. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24(1):193-209.

  9. Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update. Front Oncol. 2018;8:211.

  10. Neves M, Marinho-Dias J, Ribeiro J, Sousa H. Epstein Barr virus strains and variations: geographic or disease-specific variants. J Med Virol. 2017;89:373-87.

  11. Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD. Multiple Epstein-Barr virus infections in healthy individuals. J Virol. 2003;77(11):6546-50.

  12. Saha A, Robertson ES. Mechanisms of B-cell oncogenesis induced by Epstein-Barr virus. J Virol. 2019;93(13). pii: e00238-19.

  13. Klein G, Kashuba E. Epstein-Barr virus: clinical diagnostics. In: Brenner's encyclopedia of genetics, 2nd edition. Academic Press; 2013. p. 508-11.

  14. Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33(1):787-821.

  15. Amon W, Farrell PJ. Reactivation of Epstein-Barr virus from latency. Rev Med Virol. 2005;15(3):149-56.

  16. Hammerschmidt W, Sugden B. Replication of Epstein-Barr viral DNA. Cold Spring Harb Perspect Biol. 2013; 5(1):a013029.

  17. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492-507.

  18. Gladson CL, Prayson RA, Liu WM. The pathobiology of glioma tumors. Annu Rev Pathol. 2010;5:33-50.

  19. Seifert M, Garbe M, Friedrich B, Mittelbronn M, Klink B. Comparative transcriptomics reveals similarities and differences between astrocytoma grades. BMC Cancer. 2015;15(1):1-22.

  20. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64(6):479-89.

  21. Kofman A, Marcinkiewicz L, Dupart E, Lyshchev A, Martynov B, Ryndin A, Kotelevskaya E, Brown J, Schiff D, Abounader R. The roles of viruses in brain tumor initiation and oncomodulation. J Neurooncol. 2011;105(3):451-66.

  22. Zhao M, Nanbo A, Sun L, Lin Z. Extracellular vesicles in Epstein-Barr virus' life cycle and pathogenesis. Microor-ganisms. 2019;7(2):48.

  23. Strojnik T, Duh D, Lah TT. Prevalence of neurotropic viruses in malignant glioma and their onco-modulatory potential. In Vivo. 2017;31(2):221-29.

  24. White MK, Pagano JS, Khalili K. Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev. 2014;27(3):463-81.

  25. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-41.

  26. Sjostrom S, Hjalmars U, Juto P,Wadell G, Hallmans G, Tjonneland A, Halkjaer J, Manjer J, Almquist M, Melin BS. Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes Control. 2011;1259-66.

  27. Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K. Prevalence of antibodies to four herpesviruses among adults with glioma and controls. Am J Epidemiol. 2001;154(2):161-5.

  28. Poltermann S, Schlehofer B, SteindorfK, Schnitzler P, Geletneky K, Schlehofer JR. Lack of association of herpes-viruses with brain tumors. J Neurovirol. 2006;12(2):90-9.

  29. Neves AM, Thompson G, Carvalheira J, Trindade JC, Rueff J, Caetano JM, Casey JW, Hermouet S. Detection and quantitative analysis of human herpesvirus in pilocytic astrocytoma. Brain Res. 2008;1221:108-14.

  30. Limam S, Missaoui N, Mestiri S, Yacoubi MT, Krifa H, Selmi B, Mokney M. Epstein-Barr virus infection in gliomas. Curr Res Transl Med. 2019 Nov;67(4):129-133.

  31. Zavala-Vega S, Castro-Escarpulli G, Hernandez-Santos H, Salinas-Lara C, Palma I, Mejia-Arangure JM, Gelista-Herrera N, Rembao-Bojorquez D, Ochoa SA, Cruz-Cordova A, Xicohtencatl-Cortes J. An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme. Pathol Res Pract. 2017;213(3):271-6.

  32. Lin CTM, Leibovitch EC, Almira-Suarez MI, Jacobson S. Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls. Infect Agent Cancer. 2016;11(1):1-10.

  33. Fonseca RF, Rosas SLB, Oliveira JA, Teixeira A, Alves G, Carvalho MD. Frequency of Epstein-Barr virus DNA sequences in human gliomas. Sao Paulo Med J. 2015;133(1):51-4.

  34. Cimino PJ, Zhao G, Wang D, Sehn JK, Lewis JS, Duncavage EJ. Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data. Exp Mol Pathol. 2014;96(3):310-5.

  35. Strong MJ, Blanchard E, Lin Z, Morris CA, Baddoo M, Taylor CM, Ware ML, Flemington EK. A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus-tumor association. Acta Neuropathol Commun. 2016;4(1):71.

  36. Hashida Y, Taniguchi A, Yawata T, Hosokawa S, Murakami M, Hiroi M, Ueba T, Daibata M. Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects. Infect Agent Cancer. 2015;10(1):1-9.

  37. Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, Thompson EJ, Meric-Bernstam F, Medeiros LJ, Weinstein JN, Su X. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013;87(16):8916-26.

  38. Blumenthal DT, Raizer JJ, Rosenblum MK, Bilsky MH, Hariharan S, Abrey LE. Primary intracranial neoplasms in patients with HIV. Neurology. 1999;52(8): 1648-51.

  39. Huang L-W, Chao S-L, Hwang J-L. Human papilloma-virus-31-related types predict better survival in cervical carcinoma. Cancer. 2004;100(2):327-34.

  40. Hermouet S, Corre I, Gassin M, Bigot-Corbel E, Sutton CA, Casey JW. Hepatitis C virus, human herpesvirus 8, and the development of plasma-cell leukemia. N Engl J Med. 2003;348(2):178-9.